Elastic (ESTC) 10-Q 1 Mar 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Jan. 31, 2024	Feb. 26, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2024
Document Transition Report	false
Entity File Number	001-38675
Entity Registrant Name	Elastic N.V.
Entity Incorporation, State or Country Code	P7
Entity Tax Identification Number	98-1756035
Title of 12(b) Security	Ordinary shares, Par Value €0.01 Per Share
Trading Symbol	ESTC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		100,807,523
Entity Central Index Key	0001707753
Current Fiscal Year End Date	--04-30
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Current assets:
Cash and cash equivalents	$ 526,893	$ 644,167
Restricted cash	2,774	2,473
Marketable securities	488,133	271,041
Accounts receivable, net of allowance for credit losses of $3,865 and $3,409 as of January 31, 2024 and April 30, 2023, respectively	229,946	260,919
Deferred contract acquisition costs	68,937	55,813
Prepaid expenses and other current assets	45,440	39,867
Total current assets	1,362,123	1,274,280
Property and equipment, net	5,512	5,092
Goodwill	319,546	303,642
Operating lease right-of-use assets	23,088	19,997
Intangible assets, net	23,822	29,104
Deferred contract acquisition costs, non-current	100,389	95,879
Deferred tax assets	218,693	7,412
Other assets	5,749	8,076
Total assets	2,058,922	1,743,482
Current liabilities:
Accounts payable	10,935	35,151
Accrued expenses and other liabilities	64,835	63,532
Accrued compensation and benefits	78,049	76,483
Operating lease liabilities	12,788	12,749
Deferred revenue	561,665	528,704
Total current liabilities	728,272	716,619
Deferred revenue, non-current	23,521	34,248
Long-term debt, net	568,341	567,543
Operating lease liabilities, non-current	15,297	13,942
Other liabilities, non-current	15,654	12,233
Total liabilities	1,351,085	1,344,585
Commitments and contingencies (Notes 8 and 9)
Shareholders’ equity:
Preference shares, €0.01 par value; 165,000,000 shares authorized, 0 shares issued and outstanding as of January 31, 2024 and April 30, 2023	0	0
Ordinary shares, par value €0.01 per share: 165,000,000 shares authorized; 100,792,010 shares issued and outstanding as of January 31, 2024 and 97,366,947 shares issued and outstanding as of April 30, 2023	1,060	1,024
Treasury stock	(369)	(369)
Additional paid-in capital	1,676,493	1,471,584
Accumulated other comprehensive loss	(18,840)	(20,015)
Accumulated deficit	(950,507)	(1,053,327)
Total shareholders’ equity	707,837	398,897
Total liabilities and shareholders’ equity	$ 2,058,922	$ 1,743,482

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) $ in Thousands	Jan. 31, 2024 USD ($) shares	Jan. 31, 2024 € / shares	Apr. 30, 2023 USD ($) shares	Apr. 30, 2023 € / shares
Allowance for doubtful accounts | $	$ 3,865		$ 3,409
Ordinary shares, shares authorized (in shares)	165,000,000
Convertible Preference Shares
Preference shares, par value ( in € / shares) | € / shares		€ 0.01		€ 0.01
Preference shares, shares authorized (in shares)	165,000,000		165,000,000
Preference shares, shares issued (in shares)	0		0
Preference shares, shares outstanding (in shares)	0		0
Ordinary Shares, Par Value of €0.01
Ordinary shares, par value (in € / shares) | € / shares		€ 0.01		€ 0.01
Ordinary shares, shares authorized (in shares)	165,000,000		165,000,000
Ordinary shares, shares issued (in shares)	100,792,010		97,366,947
Ordinary shares, shares outstanding (in shares)	100,792,010		97,366,947

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Revenue
Total revenue	$ 327,957	$ 274,566	$ 932,322	$ 789,048
Cost of revenue
Total cost of revenue	84,642	75,208	242,208	222,944
Gross profit	243,315	199,358	690,114	566,104
Operating expenses
Research and development	87,202	77,472	248,000	231,689
Sales and marketing	141,621	126,717	408,020	379,902
General and administrative	40,896	34,711	117,530	103,724
Restructuring and other related charges	0	29,805	754	29,805
Total operating expenses	269,719	268,705	774,304	745,120
Operating loss	(26,404)	(69,347)	(84,190)	(179,016)
Interest Expense	(6,368)	(6,265)	(19,023)	(18,875)
Other Nonoperating Income (Expense)	8,568	5,460	24,107	20,774
Loss before income taxes	(24,204)	(70,152)	(79,106)	(177,117)
(Benefit from) provision for income taxes	(200,328)	2,422	(181,926)	12,313
Net income (loss)	$ 176,124	$ (72,574)	$ 102,820	$ (189,430)
Net earnings (loss) per share attributable to ordinary shareholders
Basic (in dollars per share)	$ 1.76	$ (0.76)	$ 1.04	$ (1.99)
Diluted (in dollars per share)	$ 1.69	$ (0.76)	$ 1	$ (1.99)
Weighted-average shares used to compute net earnings (loss) per share attributable to ordinary shareholders
Basic (in shares)	100,282,179	96,052,025	99,099,210	95,327,131
Diluted (in shares)	104,503,290	96,052,025	103,149,384	95,327,131
Total subscription
Revenue
Total revenue	$ 307,632	$ 255,613	$ 865,622	$ 728,638
Cost of revenue
Total cost of revenue	63,976	56,146	181,238	164,798
Professional services
Revenue
Total revenue	20,325	18,953	66,700	60,410
Cost of revenue
Total cost of revenue	$ 20,666	$ 19,062	$ 60,970	$ 58,146

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 176,124	$ (72,574)	$ 102,820	$ (189,430)
Other comprehensive income (loss):
Unrealized gain on available-for-sale securities	2,606	0	999	0
Foreign currency translation adjustments	2,362	7,032	176	(1,874)
Other comprehensive income (loss)	4,968	7,032	1,175	(1,874)
Total comprehensive income (loss)	$ 181,092	$ (65,542)	$ 103,995	$ (191,304)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders’ Equity - USD ($) $ in Thousands	Total	Ordinary Shares	Treasury Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2022		94,174,914
Beginning balance at Apr. 30, 2022	$ 415,433	$ 990	$ (369)	$ 1,250,108	$ (18,130)	$ (817,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of stock options (in shares)		773,174
Issuance of ordinary shares upon exercise of stock options	12,234	$ 9		12,225
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares)		1,487,188
Issuance of ordinary shares upon release of restricted stock units	0	$ 15		(15)
Stock-based compensation	148,626			148,626
Net income (loss)	(189,430)					(189,430)
Foreign currency translation	(1,874)				(1,874)
Ending balance (in shares) at Jan. 31, 2023		96,435,276
Ending balance at Jan. 31, 2023	384,989	$ 1,014	(369)	1,410,944	(20,004)	(1,006,596)
Beginning balance (in shares) at Oct. 31, 2022		95,575,775
Beginning balance at Oct. 31, 2022	391,565	$ 1,005	(369)	1,351,987	(27,036)	(934,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of stock options (in shares)		289,098
Issuance of ordinary shares upon exercise of stock options	4,510	$ 3		4,507
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares)		570,403
Issuance of ordinary shares upon release of restricted stock units	0	$ 6		(6)
Stock-based compensation	54,456			54,456
Net income (loss)	(72,574)					(72,574)
Foreign currency translation	7,032				7,032
Ending balance (in shares) at Jan. 31, 2023		96,435,276
Ending balance at Jan. 31, 2023	384,989	$ 1,014	(369)	1,410,944	(20,004)	(1,006,596)
Beginning balance (in shares) at Apr. 30, 2023		97,366,947
Beginning balance at Apr. 30, 2023	398,897	$ 1,024	(369)	1,471,584	(20,015)	(1,053,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of stock options (in shares)		1,200,589
Issuance of ordinary shares upon exercise of stock options	19,490	$ 13		19,477
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares)		2,030,369
Issuance of ordinary shares upon release of restricted stock units	0	$ 21		(21)
Issuance of ordinary shares under employee stock purchase plan (in shares)		194,105
Issuance of ordinary shares under employee stock purchase plan	9,111	$ 2		9,109
Stock-based compensation	176,344			176,344
Net income (loss)	102,820					102,820
Foreign currency translation	1,175				1,175
Ending balance (in shares) at Jan. 31, 2024		100,792,010
Ending balance at Jan. 31, 2024	707,837	$ 1,060	(369)	1,676,493	(18,840)	(950,507)
Beginning balance (in shares) at Oct. 31, 2023		99,599,262
Beginning balance at Oct. 31, 2023	455,136	$ 1,048	(369)	1,604,896	(23,808)	(1,126,631)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of stock options (in shares)		485,203
Issuance of ordinary shares upon exercise of stock options	8,847	$ 6		8,841
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares)		707,545
Issuance of ordinary shares upon release of restricted stock units	0	$ 6		(6)
Stock-based compensation	62,762			62,762
Net income (loss)	176,124					176,124
Foreign currency translation	4,968				4,968
Ending balance (in shares) at Jan. 31, 2024		100,792,010
Ending balance at Jan. 31, 2024	$ 707,837	$ 1,060	$ (369)	$ 1,676,493	$ (18,840)	$ (950,507)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)
Cash flows from operating activities
Net income (loss)	$ 102,820	$ (189,430)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	13,853	15,475
Amortization of premium and accretion of discount on marketable securities, net	(6,396)	0
Amortization of deferred contract acquisition costs	56,392	51,495
Amortization of debt issuance costs	798	763
Non-cash operating lease cost	8,148	8,354
Asset impairment charges	0	6,242
Stock-based compensation expense	176,344	148,626
Deferred income taxes	(210,278)	68
Foreign currency transaction loss	(2,267)	(2,261)
Other	(34)	67
Changes in operating assets and liabilities, net of impact of business acquisitions:
Accounts receivable, net	31,044	14,050
Deferred contract acquisition costs	(74,089)	(68,184)
Prepaid expenses and other current assets	(5,512)	7,671
Other assets	639	7,106
Accounts payable	(25,212)	511
Accrued expenses and other liabilities	1,428	(6,272)
Accrued compensation and benefits	1,509	(161)
Operating lease liabilities	(9,096)	(8,404)
Deferred revenue	23,189	17,869
Net cash provided by operating activities	87,814	8,107
Cash flows from investing activities
Purchases of property and equipment	(2,605)	(1,019)
Business acquisitions, net of cash acquired	(18,951)	0
Purchases of marketable securities	358,273	0
Maturities of marketable securities	150,223	0
Net cash used in investing activities	(229,606)	(1,019)
Cash flows from financing activities
Proceeds from issuance of ordinary shares under employee stock purchase plan	9,111	0
Proceeds from issuance of ordinary shares upon exercise of stock options	19,490	12,234
Net cash provided by financing activities	28,601	12,234
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(3,782)	(2,914)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(116,973)	16,408
Cash, cash equivalents, and restricted cash, beginning of period	646,640
Cash, cash equivalents, and restricted cash, end of period	529,667
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations		880,045
Supplemental disclosures of cash flow information
Cash paid for interest	24,156	24,041
Cash paid for income taxes, net	19,764	6,536
Cash paid for operating lease liabilities	10,510	9,814
Supplemental disclosures of non-cash investing and financing information
Changes in property and equipment included in accounts payable	359	25
Operating lease right-of-use assets for new lease obligations	11,235	10,901
Acquisition-related indemnity holdback	$ 3,125	$ 0

Organization and Description of

Organization and Description of Business	9 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Elastic N.V. (individually and together with its consolidated subsidiaries, “Elastic” or the “Company”) was incorporated under the laws of the Netherlands in 2012. The Company created the Elastic Stack, a powerful set of software products that ingest and store data from any source and in any format, and perform search, analysis, and visualization on that data. Developers build on top of the Elastic Stack to apply the power of search to their data and solve business problems. The Company offers three software solutions built into the Elastic Stack: Search, Observability, and Security. The Elastic Stack and the Company’s solutions are designed to run across hybrid clouds, public or private clouds, and multi-cloud environments.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying interim condensed consolidated balance sheet as of January 31, 2024, interim condensed consolidated statements of operations, comprehensive income (loss), and shareholders’ equity for the three and nine months ended January 31, 2024 and 2023, and interim condensed consolidated statements of cash flows for the nine months ended January 31, 2024 and 2023 are unaudited. These interim condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary to fairly state the Company’s financial position as of January 31, 2024; results of the Company’s operations for the three and nine months ended January 31, 2024 and 2023; statements of shareholders’ equity for the three and nine months ended January 31, 2024 and 2023; and statements of cash flows for the nine months ended January 31, 2024 and 2023. The financial data and other financial information disclosed in the notes to these interim condensed consolidated financial statements related to the three and nine month periods are also unaudited. The results for the three and nine months ended January 31, 2024 are not necessarily indicative of the operating results expected for the fiscal year ending April 30, 2024, or any other future period. The unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the financial statements of the Company and its wholly-owned subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed balance sheet data as of April 30, 2023 was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. Therefore, these unaudited interim condensed consolidated financial statements and accompanying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2023 filed with the SEC on June 16, 2023 (the “Company’s Annual Report on Form 10-K”). Fiscal Year The Company’s fiscal year ends on April 30. References to fiscal 2024, for example, refer to the fiscal year ended April 30, 2024. Use of Estimates and Judgments The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates and assumptions include, but are not limited to, allocation of revenue between recognized and deferred amounts, deferred contract acquisition costs, allowance for credit losses, valuation of stock-based compensation, fair value of ordinary shares in periods prior to the Company’s initial public offering, fair value of acquired intangible assets and goodwill, useful lives of acquired intangible assets and property and equipment, whether an arrangement is or contains a lease, discount rate used for operating leases, and valuation allowance for deferred income taxes. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require the exercise of judgment. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments or revise the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements. Significant Accounting Policies There have been no changes to the Company’s significant accounting policies described in the Company’s Annual Report on Form 10-K that have had a material impact on its condensed consolidated financial statements and related notes. Recently Adopted Accounting Pronouncements Acquisitions: In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, improving consistency in accounting for acquired revenue contracts with customers in a business combination by requiring that acquirers apply ASC 606 to recognize contract assets and contract liabilities as if they had originated the contracts. If the acquiree prepared its financial statements in accordance with U.S. GAAP, the resulting acquired contract assets and liabilities should generally be consistent with the acquiree’s financial statements. The Company adopted ASU No. 2021-08 on May 1, 2023. The Company’s adoption of this ASU did not have a material impact on its condensed consolidated financial statements. New Accounting Pronouncements Not Yet Adopted Income Taxes: In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, requiring enhancements and further transparency to certain income tax disclosures. The new guidance requires consistent categories and greater disaggregation of information in the tax rate reconciliation and information about income taxes paid disaggregated by jurisdiction. The guidance becomes effective for the Company for the fiscal year ending April 30, 2026. Early adoption is permitted. Upon adoption, the guidance may be applied prospectively or retrospectively. The Company is currently evaluating the impact of adopting this standard on its condensed consolidated financial statements.

Revenue

Revenue	9 Months Ended
	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table presents revenue by category (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Elastic Cloud $ 143,379 44 % $ 110,743 40 % $ 399,540 43 % $ 311,709 40 % Other subscription 164,253 50 % 144,870 53 % 466,082 50 % 416,929 52 % Total subscription 307,632 94 % 255,613 93 % 865,622 93 % 728,638 92 % Services 20,325 6 % 18,953 7 % 66,700 7 % 60,410 8 % Total revenue $ 327,957 100 % $ 274,566 100 % $ 932,322 100 % $ 789,048 100 % Concentration of Credit Risk No customer accounted for 10% or more of the Company’s net accounts receivable as of January 31, 2024. One customer, a channel partner, accounted for 12% of net accounts receivable as of April 30, 2023. The same customer accounted for 11% of total revenue during the three and nine months ended January 31, 2024. No customer accounted for 10% or more of the Company’s total revenue for the three and nine months ended January 31, 2023. Deferred Revenue Unbilled Accounts Receivable Remaining Performance Obligations As of January 31, 2024, the Company had $1.176 billion of remaining performance obligations. As of January 31, 2024, the Company expects to recognize approximately 91% of its remaining performance obligations as revenue over the next 24 months and the remainder thereafter. Deferred Contract Acquisition Costs Amortization expense with respect to deferred contract acquisition costs was $20.4 million and $56.4 million for the three and nine months ended January 31, 2024, respectively, and $15.8 million and $51.5 million for the three and nine months ended January 31, 2023, respectively. The Company did not recognize any impairment of deferred contract acquisition costs for the periods presented.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Financial Assets The Company measures financial assets and liabilities that are measured at fair value on a recurring basis at each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company considers all highly liquid investments, including money market funds with an original maturity of three months or less at the date of purchase, to be cash equivalents. The Company’s marketable securities are classified as available for sale and considered to be available for use in current operations and, therefore, the Company classifies them within current assets on the condensed consolidated balance sheet. The Company uses quoted prices in active markets for identical assets to determine the fair value of its Level 1 investments. For Level 2 investments, the Company uses inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded. The following table summarizes assets that are measured at fair value on a recurring basis as of January 31, 2024 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 189,846 $ — $ — $ 189,846 U.S. treasury securities 14,993 — — 14,993 Certificates of deposit — 2,230 — 2,230 Total included in cash and cash equivalents 204,839 2,230 — 207,069 Marketable securities: Certificates of deposit — 33,177 — 33,177 Commercial paper — 38,757 — 38,757 Municipal securities — 25,894 — 25,894 U.S. treasury securities 109,777 — — 109,777 International treasuries — 7,188 — 7,188 Corporate debt securities — 232,030 — 232,030 U.S. agency bonds — 41,310 — 41,310 Total marketable securities 109,777 378,356 — 488,133 Total financial assets $ 314,616 $ 380,586 $ — $ 695,202 The following table summarizes assets that are measured at fair value on a recurring basis as of April 30, 2023 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 194,261 $ — $ — $ 194,261 U.S. agency securities — 27,406 — 27,406 Certificates of deposit — 21,750 — 21,750 Commercial paper — 60,750 — 60,750 Total included in cash and cash equivalents 194,261 109,906 — 304,167 Marketable securities: Certificates of deposit — 31,645 — 31,645 Commercial paper — 33,735 — 33,735 U.S. treasury securities 47,627 — — 47,627 Corporate debt securities — 118,228 — 118,228 U.S. agency bonds — 39,806 — 39,806 Total marketable securities 47,627 223,414 — 271,041 Total financial assets $ 241,888 $ 333,320 $ — $ 575,208 Interest income from the Company’s cash, cash equivalents and marketable securities was $7.8 million and $20.9 million for the three and nine months ended January 31, 2024, respectively, and $6.2 million and $10.9 million for the three and nine months ended January 31, 2023, respectively, and is included in other income, net in the condensed consolidated statements of operations. As of January 31, 2024 and April 30, 2023, unrealized gains and losses on the marketable securities were immaterial. The fluctuations in market interest rates impact the unrealized losses or gains on these securities. The fair value of available-for-sale securities, by remaining contractual maturity, are as follows (in thousands): As of As of Due within 1 year $ 252,415 $ 168,264 Due between 1 year and 3 years 235,718 102,777 Total marketable securities $ 488,133 $ 271,041 Financial Liabilities In July 2021, the Company issued $575.0 million aggregate principal amount of 4.125% Senior Notes due July 15, 2029 (the “Senior Notes”) in a private placement. Based on the trading prices of the Senior Notes, the fair value of the Senior Notes as of January 31, 2024 was approximately $523.0 million. While the Senior Notes are recorded at cost, the fair value of the Senior Notes was determined based on quoted prices in markets that are not active; accordingly, the Senior Notes are categorized as Level 2 for purposes of the fair value measurement hierarchy.

Acquisitions

Acquisitions	9 Months Ended
	Jan. 31, 2024
Business Combinations [Abstract]
Acquisitions	Acquisitions Opster Ltd. On November 30, 2023, the Company acquired 100% of the share capital of Opster Ltd. (“Opster”) for a total purchase consideration of $22.8 million. The purchase consideration includes $3.1 million held back by the Company for indemnity obligations which will be released upon the 18-month anniversary of the acquisition. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations, and, accordingly, the total purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date. The total purchase price allocated to developed technology and goodwill was $6.0 million and $15.9 million, respectively. The fair value assigned to developed technology was determined using the cost to recreate approach. The developed technology asset is being amortized on a straight-line basis over the useful life of 5 years, which approximates the pattern in which the developed technology is utilized. Goodwill resulted primarily from the expectation of enhancing the efficiency and management of the Elastic Stack and is not deductible for income tax purposes.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Jan. 31, 2024
Balance Sheet Components [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, Net The cost and accumulated depreciation of property and equipment were as follows (in thousands): Useful Life (in years) As of As of Leasehold improvements Lesser of estimated useful life or remaining lease term $ 12,281 $ 10,081 Computer hardware and software 3 3,310 2,220 Furniture and fixtures 3-5 6,898 6,093 Assets under construction 651 1,734 Total property and equipment 23,140 20,128 Less: accumulated depreciation (17,628) (15,036) Property and equipment, net $ 5,512 $ 5,092 Depreciation expense related to property and equipment was $0.9 million and $2.6 million for the three and nine months ended January 31, 2024, respectively, and $0.8 million and $2.9 million for the three and nine months ended January 31, 2023, respectively. During the three and nine months ended January 31, 2023, the Company recorded asset impairment charges related to the exit from leased office space, which included $1.1 million of furniture, equipment, and leasehold improvements. See Note 16 for further details. Intangible Assets, Net Intangible assets consisted of the following as of January 31, 2024 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 76,130 $ 52,275 $ 23,855 2.8 Customer relationships 19,598 19,598 — 0.0 Trade names 2,872 2,872 — 0.0 Total $ 98,600 $ 74,745 $ 23,855 2.8 Foreign currency translation adjustment (33) Total $ 23,822 Intangible assets consisted of the following as of April 30, 2023 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 70,130 $ 43,136 $ 26,994 2.7 Customer relationships 19,598 17,641 1,957 0.4 Trade names 2,872 2,686 186 0.4 Total $ 92,600 $ 63,463 $ 29,137 2.5 Foreign currency translation adjustment (33) Total $ 29,104 Amortization expense for the intangible assets for the three and nine months ended January 31, 2024 and 2023 was as follows (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Cost of revenue – subscription $ 3,186 $ 2,977 $ 9,139 $ 8,902 Sales and marketing — 1,232 2,143 3,695 Total amortization of acquired intangible assets $ 3,186 $ 4,209 $ 11,282 $ 12,597 The expected future amortization expense related to the intangible assets as of January 31, 2024 was as follows (in thousands, by fiscal year): Remainder of 2024 $ 3,098 2025 9,239 2026 6,278 2027 3,267 2028 1,224 Thereafter 716 Total $ 23,822 Goodwill The following table represents the changes to goodwill (in thousands): Carrying Amount Balance as of April 30, 2023 $ 303,642 Addition from acquisition 15,830 Foreign currency translation adjustment 74 Balance as of January 31, 2024 $ 319,546 There was no impairment of goodwill during the nine months ended January 31, 2024 and 2023. Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): As of As of Accrued expenses $ 30,697 $ 24,163 Income taxes payable 14,628 9,738 Value added taxes payable 5,360 9,403 Accrued interest 988 6,918 Other 13,162 13,310 Total accrued expenses and other liabilities $ 64,835 $ 63,532 Accrued Compensation and Benefits Accrued compensation and benefits consisted of the following (in thousands): As of As of Accrued vacation $ 31,346 $ 30,026 Accrued commissions 18,946 26,175 Accrued payroll and withholding taxes 13,495 6,586 Other 14,262 13,696 Total accrued compensation and benefits $ 78,049 $ 76,483 Allowance for Credit Losses The following is a summary of the changes in the Company’s allowance for credit losses (in thousands): Nine Months Ended January 31, 2024 2023 Beginning balance $ 3,409 $ 2,700 Bad debt expense 2,189 1,276 Accounts written off (1,733) (1,781) Ending balance $ 3,865 $ 2,195

Senior Notes

Senior Notes	9 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Senior Notes	Senior Notes In July 2021, the Company issued $575.0 million aggregate principal amount of 4.125% Senior Notes due July 15, 2029 in a private placement. Interest on the Senior Notes is payable semi-annually in arrears on January 15 and July 15 of each year. The Company received net proceeds from the offering of the Senior Notes of $565.7 million after deducting underwriting commissions of $7.2 million and incurred additional issuance costs of $2.1 million. Total debt issuance costs of $9.3 million are being amortized to interest expense using the effective interest method over the term of the Senior Notes. The Company may redeem the Senior Notes, in whole or in part, at any time prior to July 15, 2024 at a price equal to 100% of the principal amount thereof plus a “make-whole” premium and accrued and unpaid interest, if any. The Company may at its election redeem all or a part of the Senior Notes on or after July 15, 2024, on any one or more occasions, at the redemption prices set forth in the indenture governing the Senior Notes (the “Indenture”), plus, in each case, accrued and unpaid interest thereon, if any, to, but excluding, the applicable redemption date. In addition, at any time prior to July 15, 2024, the Company may on any one or more occasions redeem up to 40% of the aggregate principal amount of the Senior Notes outstanding under the Indenture with the net cash proceeds of one or more equity offerings at a redemption price equal to 104.125% of the principal amount of the Senior Notes then outstanding, plus accrued and unpaid interest thereon, if any, to, but excluding, the applicable redemption date. The Company may also at its election redeem the Senior Notes in whole, but not in part, at a price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, if certain changes in tax law occur as set forth in the Indenture. If the Company experiences a change of control triggering event (as defined in the Indenture), the Company must offer to repurchase the Senior Notes at a repurchase price equal to 101% of the principal amount of the Senior Notes to be repurchased, plus accrued and unpaid interest, if any, to the repurchase date. The Indenture contains covenants limiting the Company’s ability and the ability of certain subsidiaries to create liens on certain assets to secure debt; grant a subsidiary guarantee of certain debt without also providing a guarantee of the Senior Notes; and consolidate or merge with or into, or sell or otherwise dispose of all or substantially all of its assets to, another person. These covenants are subject to a number of limitations and exceptions. Certain of these covenants will not apply during any period in which the Senior Notes are rated investment grade by Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services. The net carrying amount of the Senior Notes was as follows (in thousands): As of As of Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (6,659) (7,457) Net carrying amount $ 568,341 $ 567,543 The following table sets forth the interest expense recognized related to the Senior Notes (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Contractual interest expense $ 5,930 $ 5,930 $ 17,789 $ 17,789 Amortization of debt issuance costs 269 257 798 763 Total interest expense related to the Senior Notes $ 6,199 $ 6,187 $ 18,587 $ 18,552

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Cloud Hosting Commitments During the nine months ended January 31, 2024, there were no material changes, outside the ordinary course of business, to the Company’s contractual obligations and commitments reported in the Company's Annual Report on Form 10-K. Letters of Credit The Company had a total of $2.3 million in letters of credit outstanding in favor of certain landlords for office space as of January 31, 2024. Legal Matters From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, results of operations, financial position or cash flows. The Company accrues estimates for resolution of legal and other contingencies when losses are probable and reasonably estimable. Indemnification The Company enters into indemnification provisions under its agreements with other companies in the ordinary course of business, including business partners, landlords, contractors and parties performing its research and development. Pursuant to these arrangements, the Company agrees to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company’s activities. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the Company believes the fair value of these agreements is not material. The Company maintains commercial general liability insurance and product liability insurance to offset certain of the Company’s potential liabilities under these indemnification provisions. In addition, the Company indemnifies its officers, directors and certain key employees against certain liabilities that may arise as a result of their affiliation with the Company. To date, there have been no claims under any indemnification provisions.

Leases

Leases	9 Months Ended
	Jan. 31, 2024
Leases [Abstract]
Leases	Leases The Company’s leases provide for rental of corporate office space under non-cancelable operating lease agreements that expire at various dates through fiscal 2030. The Company does not have any finance leases. Lease Costs Components of lease costs included in the condensed consolidated statements of operations were as follows (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Operating lease cost $ 3,120 $ 3,088 $ 8,960 $ 9,539 Short-term lease cost 334 381 1,308 1,729 Variable lease cost 527 219 1,049 446 Total lease cost $ 3,981 $ 3,688 $ 11,317 $ 11,714 Lease term and discount rate information are summarized as follows: As of Weighted average remaining lease term (in years) 2.85 Weighted average discount rate 5.10 % Future minimum lease payments under non-cancelable operating leases on an undiscounted cash flow basis as of January 31, 2024 were as follows (in thousands, by fiscal year): Remainder of 2024 $ 3,603 2025 12,955 2026 7,398 2027 2,704 2028 2,359 Thereafter 1,101 Total minimum lease payments 30,120 Less imputed interest (2,035) Present value of future minimum lease payments 28,085 Less current lease liabilities (12,788) Operating lease liabilities, non-current $ 15,297 Future minimum lease payments as of January 31, 2024 include future cash payments on leases with corresponding right-of-use assets which were written down for impairment due to facilities-related cost optimization actions during the three and nine months ended January 31, 2023. During the three and nine months ended January 31, 2023, the Company recorded an impairment charge of $5.1 million related to the exit from leased office space. See Note 16 for further details.

Ordinary Shares

Ordinary Shares	9 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Ordinary Shares	Ordinary Shares The Company’s authorized ordinary share capital pursuant to its articles of association amounts to 165 million ordinary shares at a par value per ordinary share of €0.01. Each holder of ordinary shares has the right to one vote per ordinary share. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available and when proposed by the Company’s board of directors and adopted by the general meeting of shareholders, subject to the prior rights of holders of all classes of shares outstanding having priority rights to dividends. No dividends have been declared from the Company’s inception through January 31, 2024. The board of directors has been authorized by the general meeting of shareholders, on the Company’s behalf, to issue the Company’s ordinary shares and grant rights to acquire the Company’s ordinary shares in an amount up to 20% of the issued share capital of the Company as of August 21, 2023. This authorization is valid for a period of 18 months from October 5, 2023. Ordinary Shares Reserved for Issuance The Company has reserved ordinary shares for issuance as follows: As of As of Stock options issued and outstanding 2,732,289 4,038,238 RSUs issued and outstanding (1) 7,895,146 7,494,399 Available for future grants 20,105,501 17,564,133 Available for employee stock purchases 5,805,895 6,000,000 Total ordinary shares reserved 36,538,831 35,096,770 (1) Includes 116,523 PSUs issued and outstanding as of January 31, 2024. Preference Shares The Company’s authorized preference share capital pursuant to its articles of association amounts to 165 million preference shares at a par value per preference share of €0.01. Each holder of preference shares has rights and preferences, including the right to one vote per preference share. As of January 31, 2024, there were no preference shares issued or outstanding. Preference shares in the capital of the Company may currently only be issued pursuant to a resolution adopted by the general meeting of shareholders at the proposal of the board of directors.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	Equity Incentive Plans 2022 Employee Stock Purchase Plan In August 2022, the Company’s board of directors adopted and, in October 2022, the Company’s shareholders approved the 2022 Employee Stock Purchase Plan (“2022 ESPP”). The Company reserved 6.0 million of the Company’s ordinary shares for future purchase and issuance under the 2022 ESPP in January 2023. The 2022 ESPP allows eligible employees to acquire ordinary shares of the Company at a discount at periodic intervals through accumulated payroll deductions. Eligible employees purchase ordinary shares of the Company during a purchase period at 85% of the market value of the Company’s ordinary shares at either the beginning or end of an offering period, whichever is lower. Offering periods under the 2022 ESPP are approximately six months long and begin on each of March 16 or September 16 or the next trading day thereafter. For the nine months ended January 31, 2024, 194,105 ordinary shares were purchased under the 2022 ESPP. No ordinary shares were purchased under the 2022 ESPP during the three months ended January 31, 2024. Stock-based compensation expense recognized related to the 2022 ESPP was $1.7 million and $5.3 million for the three and nine months ended January 31, 2024, respectively. 2012 Stock Option Plan In September 2012, the Company’s board of directors adopted and the Company’s shareholders approved the 2012 Stock Option Plan, which was amended and restated in September 2018 and further amended in December 2021 (as amended and restated, the “2012 Plan”). Under the 2012 Plan, the board of directors, the compensation committee, as administrator of the 2012 Plan, and any other duly authorized committee may grant stock options and other equity-based awards, such as Restricted Stock Awards (“RSAs”), Restricted Stock Units (“RSUs”), and performance-based RSUs (“PSUs”), to eligible employees, directors, and consultants to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors and consultants, and to promote the success of the Company’s business. The Company’s board of directors, compensation committee, or other duly authorized committee determines the vesting schedule for all equity-based awards. Stock options and RSUs granted to employees generally vest over four years, subject to the employees’ continued service to the Company. During the nine months ended January 31, 2024, the Company granted PSUs that vest over three years with a one-year performance period. The Company’s compensation committee may explicitly deviate from the general vesting schedules in its approval of an equity-based award, as it may deem appropriate. Stock options expire ten years after the date of grant. Stock options, RSAs and RSUs (including PSUs) that are canceled under certain conditions become available for future grant or sale under the 2012 Plan unless the 2012 Plan is terminated. The equity awards available for grant were as follows: Nine Months Ended January 31, 2024 Available at beginning of fiscal year 17,564,133 Awards authorized 4,868,347 Options canceled 104,137 RSUs granted (1) (3,261,660) RSUs canceled (2) 830,544 Available at end of period 20,105,501 (1) Includes 132,960 PSUs granted during the nine months ended January 31, 2024. (2) Includes 16,437 PSUs canceled during the nine months ended January 31, 2024. Stock Options The following table summarizes stock option activity: Stock Options Outstanding Number of Stock Options Outstanding Weighted- Average Exercise Price Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Balance as of April 30, 2023 4,038,238 $ 32.74 5.35 $ 134,778 Stock options exercised (1,200,589) $ 16.23 Stock options canceled (104,137) $ 98.35 Stock options assumed in acquisition canceled (1,223) $ 75.42 Balance as of January 31, 2024 2,732,289 $ 37.47 4.89 $ 223,029 Exercisable as of January 31, 2024 2,439,399 $ 30.88 4.57 $ 214,206 Aggregate intrinsic value represents the difference between the exercise price of the stock options to purchase the Company’s ordinary shares and the fair value of the Company’s ordinary shares. The weighted-average grant-date fair value per share of stock options granted was $48.56 for the nine months ended January 31, 2023. No stock options were granted during the three months ended January 31, 2023. As of January 31, 2024, the Company had unrecognized stock-based compensation expense of $15.8 million related to unvested stock options that the Company expects to recognize over a weighted-average period of 1.83 years. RSUs The following table summarizes RSU activity under the 2012 Plan: Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at April 30, 2023 7,494,399 $ 74.52 RSUs granted (1) 3,261,660 $ 102.08 RSUs released (2,030,369) $ 79.51 RSUs canceled (2) (830,544) $ 74.41 Outstanding and unvested at January 31, 2024 7,895,146 $ 84.64 (1) Includes 132,960 PSUs granted during the nine months ended January 31, 2024. (2) Includes 16,437 PSUs canceled during the nine months ended January 31, 2024. During the nine months ended January 31, 2024, the Company granted 132,960 PSUs subject to performance and service conditions, with a grant-date fair value of $9.1 million, to certain executives. The PSUs become eligible to vest based on the level of the Company’s achievement against a revenue-based performance goal for fiscal 2024. The amount that may be earned ranges from 0% to 200% of the eligible PSUs. Subject to the executives’ continued service to the Company through the applicable vesting date, one-third of the eligible PSUs will vest following the end of fiscal 2024 and, thereafter, one-eighth of the remaining eligible PSUs will vest on a quarterly basis over two years. Compensation expense related to PSUs is measured at the fair value on the date of grant and recognized over the requisite service period. In the event that an executive’s continuous service to the Company ceases, any associated unvested PSUs will immediately terminate and be forfeited. The Company recognizes forfeitures as they occur. As of January 31, 2024, the Company had unrecognized stock-based compensation expense of $624.8 million related to RSUs (including PSUs) that the Company expects to recognize over a weighted-average period of 2.97 years. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations was as follows (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Cost of revenue Subscription $ 2,253 $ 2,163 $ 6,553 $ 6,352 Services 3,331 2,529 8,980 7,067 Research and development 24,443 20,905 68,843 58,378 Sales and marketing 20,238 19,096 57,252 50,756 General and administrative 12,497 9,763 34,716 26,073 Total stock-based compensation expense $ 62,762 $ 54,456 $ 176,344 $ 148,626

Net Earnings (Loss) Per Share A

Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders	9 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders	Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders The following table sets forth the computation of basic and diluted net earnings (loss) per share attributable to ordinary shareholders (in thousands, except share and per share data): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Numerator: Net income (loss) $ 176,124 $ (72,574) $ 102,820 $ (189,430) Denominator: Weighted-average shares used in computing net earnings (loss) per share attributable to ordinary shareholders Basic 100,282,179 96,052,025 99,099,210 95,327,131 Diluted 104,503,290 96,052,025 103,149,384 95,327,131 Net earnings (loss) per share attributable to ordinary shareholders, basic and diluted Basic $ 1.76 $ (0.76) $ 1.04 $ (1.99) Diluted $ 1.69 $ (0.76) $ 1.00 $ (1.99) The following outstanding potentially dilutive ordinary shares were excluded from the computation of diluted net earnings (loss) per share attributable to ordinary shareholders for the periods presented because the impact of including them would have been antidilutive: Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Stock options 344,995 4,419,457 780,199 4,419,457 RSUs 1,858,725 8,021,408 1,467,263 8,021,408 2022 ESPP — — 641 — Total 2,203,720 12,440,865 2,248,103 12,440,865

Income Taxes

Income Taxes	9 Months Ended
	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company is incorporated in the Netherlands but operates in various countries with differing tax laws and rates. The Company recorded a benefit from income taxes of $200.3 million and a provision for tax expense of $2.4 million for the three months ended January 31, 2024 and 2023, respectively, and a benefit of $181.9 million and expense of $12.3 million for the nine months ended January 31, 2024 and 2023, respectively. The calculation of income taxes is based upon the estimated annual effective tax rates for the year applied to the current period income before tax plus the tax effect of any significant unusual items, discrete events, or changes in tax law. The income tax benefit for the three and nine months ended January 31, 2024 was primarily due to the release of the valuation allowance against U.S. federal and certain states’ deferred tax assets of $250.7 million during the three and nine months ended January 31, 2024. The Company regularly assesses the need for a valuation allowance against its deferred tax assets. In making that assessment, the Company considers both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. As of January 31, 2024, based on all available positive and negative evidence, having demonstrated sustained profitability which is objective and verifiable, and taking into account anticipated future earnings, the Company has determined that it is more likely than not that its U.S. federal and certain states’ deferred tax assets will be realizable. The Company continues to maintain a valuation allowance against California and certain other states’ deferred tax assets due to the uncertainty regarding the realizability as they have not met the “more likely than not” realization criteria. When a change in valuation allowance is recognized during an interim period, the change in valuation allowance resulting from current year income is included in the annual effective tax rate, and the release of valuation allowance, supported by projections of future taxable income, is recorded as a discrete tax benefit in the interim period. The Company released $207.5 million of its valuation allowance as a discrete tax benefit during the three months ended January 31, 2024. The Company will continue to regularly assess the need for a valuation allowance against its deferred tax assets. The Company assesses uncertain tax positions in accordance with ASC 740-10, Accounting for Uncertainties in Tax. The Company anticipates that the amount of reasonably possible unrecognized tax benefits that could decrease over the next twelve months due to the expiration of certain statutes of limitations and settlement of tax audits is not material to the Company’s condensed consolidated financial statements.

Employee Benefit Plans

Employee Benefit Plans	9 Months Ended
	Jan. 31, 2024
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans The Company has a defined-contribution plan in the United States intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company has contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all the expenses incurred for administering the 401(k) Plan are paid by the Company. The 401(k) Plan covers substantially all U.S. employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. The Company makes contributions to the 401(k) Plan up to 6% of the participating employee’s W-2 earnings and wages. The Company recorded $4.2 million and $4.4 million of expense related to the 401(k) Plan for the three months ended January 31, 2024 and 2023, respectively, and $13.3 million and $13.4 million for the nine months ended January 31, 2024 and 2023, respectively.

Segment Information

Segment Information	9 Months Ended
	Jan. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information The following table summarizes the Company’s total revenue by geographic area based on the location of customers (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 United States $ 186,177 $ 159,125 $ 537,392 $ 464,186 Rest of world 141,780 115,441 394,930 324,862 Total revenue $ 327,957 $ 274,566 $ 932,322 $ 789,048 Other than the United States, no individual country exceeded 10% or more of total revenue during the periods presented. The following table presents the Company’s long-lived assets, including property and equipment, net, and operating lease right-of-use assets, by geographic region (in thousands): As of As of United States $ 11,983 $ 13,476 The Netherlands 3,959 4,597 United Kingdom 4,030 2,797 India 2,679 1,803 Rest of world 5,949 2,416 Total long-lived assets $ 28,600 $ 25,089

Restructuring and Other Related

Restructuring and Other Related Charges	9 Months Ended
	Jan. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	Restructuring and Other Related Charges On November 30, 2022, the Company announced and began implementing a plan to align its investments more closely with its strategic priorities by reducing the Company’s workforce by approximately 13% and implementing certain facilities-related cost optimization actions. For the nine months ended January 31, 2024, the Company recorded $0.8 million of employee-related severance and other termination benefits. The Company did not record employee-related severance and other termination benefits for the three months ended January 31, 2024. For the three and nine months ended January 31, 2023, the Company recorded employee-related severance and other termination benefits of approximately $22.0 million and facilities-related charges of approximately $6.2 million. The facilities-related charges included impairment of operating lease right-of-use assets and the associated furniture, equipment, and leasehold improvements of $5.1 million and $1.1 million, respectively, for the exited leased office spaces.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 176,124	$ (72,574)	$ 102,820	$ (189,430)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jan. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Jan. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim condensed consolidated balance sheet as of January 31, 2024, interim condensed consolidated statements of operations, comprehensive income (loss), and shareholders’ equity for the three and nine months ended January 31, 2024 and 2023, and interim condensed consolidated statements of cash flows for the nine months ended January 31, 2024 and 2023 are unaudited. These interim condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary to fairly state the Company’s financial position as of January 31, 2024; results of the Company’s operations for the three and nine months ended January 31, 2024 and 2023; statements of shareholders’ equity for the three and nine months ended January 31, 2024 and 2023; and statements of cash flows for the nine months ended January 31, 2024 and 2023. The financial data and other financial information disclosed in the notes to these interim condensed consolidated financial statements related to the three and nine month periods are also unaudited. The results for the three and nine months ended January 31, 2024 are not necessarily indicative of the operating results expected for the fiscal year ending April 30, 2024, or any other future period. The unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the financial statements of the Company and its wholly-owned subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed balance sheet data as of April 30, 2023 was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. Therefore, these unaudited interim condensed consolidated financial statements and accompanying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2023 filed with the SEC on June 16, 2023 (the “Company’s Annual Report on Form 10-K”).
Fiscal Year	Fiscal Year The Company’s fiscal year ends on April 30. References to fiscal 2024, for example, refer to the fiscal year ended April 30, 2024.
Use of Estimates and Judgments	Use of Estimates and Judgments The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates and assumptions include, but are not limited to, allocation of revenue between recognized and deferred amounts, deferred contract acquisition costs, allowance for credit losses, valuation of stock-based compensation, fair value of ordinary shares in periods prior to the Company’s initial public offering, fair value of acquired intangible assets and goodwill, useful lives of acquired intangible assets and property and equipment, whether an arrangement is or contains a lease, discount rate used for operating leases, and valuation allowance for deferred income taxes. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require the exercise of judgment. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments or revise the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements.
Recently Adopted Accounting Pronouncements And New Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements Acquisitions: In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, improving consistency in accounting for acquired revenue contracts with customers in a business combination by requiring that acquirers apply ASC 606 to recognize contract assets and contract liabilities as if they had originated the contracts. If the acquiree prepared its financial statements in accordance with U.S. GAAP, the resulting acquired contract assets and liabilities should generally be consistent with the acquiree’s financial statements. The Company adopted ASU No. 2021-08 on May 1, 2023. The Company’s adoption of this ASU did not have a material impact on its condensed consolidated financial statements. New Accounting Pronouncements Not Yet Adopted Income Taxes: In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, requiring enhancements and further transparency to certain income tax disclosures. The new guidance requires consistent categories and greater disaggregation of information in the tax rate reconciliation and information about income taxes paid disaggregated by jurisdiction. The guidance becomes effective for the Company for the fiscal year ending April 30, 2026. Early adoption is permitted. Upon adoption, the guidance may be applied prospectively or retrospectively. The Company is currently evaluating the impact of adopting this standard on its condensed consolidated financial statements.

Revenue and Performance Obligat

Revenue and Performance Obligations (Tables)	9 Months Ended
	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from External Customers by Products and Services	The following table presents revenue by category (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Elastic Cloud $ 143,379 44 % $ 110,743 40 % $ 399,540 43 % $ 311,709 40 % Other subscription 164,253 50 % 144,870 53 % 466,082 50 % 416,929 52 % Total subscription 307,632 94 % 255,613 93 % 865,622 93 % 728,638 92 % Services 20,325 6 % 18,953 7 % 66,700 7 % 60,410 8 % Total revenue $ 327,957 100 % $ 274,566 100 % $ 932,322 100 % $ 789,048 100 %

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on Recurring Basis	The following table summarizes assets that are measured at fair value on a recurring basis as of January 31, 2024 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 189,846 $ — $ — $ 189,846 U.S. treasury securities 14,993 — — 14,993 Certificates of deposit — 2,230 — 2,230 Total included in cash and cash equivalents 204,839 2,230 — 207,069 Marketable securities: Certificates of deposit — 33,177 — 33,177 Commercial paper — 38,757 — 38,757 Municipal securities — 25,894 — 25,894 U.S. treasury securities 109,777 — — 109,777 International treasuries — 7,188 — 7,188 Corporate debt securities — 232,030 — 232,030 U.S. agency bonds — 41,310 — 41,310 Total marketable securities 109,777 378,356 — 488,133 Total financial assets $ 314,616 $ 380,586 $ — $ 695,202 The following table summarizes assets that are measured at fair value on a recurring basis as of April 30, 2023 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 194,261 $ — $ — $ 194,261 U.S. agency securities — 27,406 — 27,406 Certificates of deposit — 21,750 — 21,750 Commercial paper — 60,750 — 60,750 Total included in cash and cash equivalents 194,261 109,906 — 304,167 Marketable securities: Certificates of deposit — 31,645 — 31,645 Commercial paper — 33,735 — 33,735 U.S. treasury securities 47,627 — — 47,627 Corporate debt securities — 118,228 — 118,228 U.S. agency bonds — 39,806 — 39,806 Total marketable securities 47,627 223,414 — 271,041 Total financial assets $ 241,888 $ 333,320 $ — $ 575,208 The fair value of available-for-sale securities, by remaining contractual maturity, are as follows (in thousands): As of As of Due within 1 year $ 252,415 $ 168,264 Due between 1 year and 3 years 235,718 102,777 Total marketable securities $ 488,133 $ 271,041

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Jan. 31, 2024
Balance Sheet Components [Abstract]
Schedule of Cost and Accumulated Depreciation of Property and Equipment	The cost and accumulated depreciation of property and equipment were as follows (in thousands): Useful Life (in years) As of As of Leasehold improvements Lesser of estimated useful life or remaining lease term $ 12,281 $ 10,081 Computer hardware and software 3 3,310 2,220 Furniture and fixtures 3-5 6,898 6,093 Assets under construction 651 1,734 Total property and equipment 23,140 20,128 Less: accumulated depreciation (17,628) (15,036) Property and equipment, net $ 5,512 $ 5,092
Schedule of Intangible Assets	Intangible assets consisted of the following as of January 31, 2024 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 76,130 $ 52,275 $ 23,855 2.8 Customer relationships 19,598 19,598 — 0.0 Trade names 2,872 2,872 — 0.0 Total $ 98,600 $ 74,745 $ 23,855 2.8 Foreign currency translation adjustment (33) Total $ 23,822 Intangible assets consisted of the following as of April 30, 2023 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 70,130 $ 43,136 $ 26,994 2.7 Customer relationships 19,598 17,641 1,957 0.4 Trade names 2,872 2,686 186 0.4 Total $ 92,600 $ 63,463 $ 29,137 2.5 Foreign currency translation adjustment (33) Total $ 29,104
Schedule of Amortization Expense for Intangible Assets	Amortization expense for the intangible assets for the three and nine months ended January 31, 2024 and 2023 was as follows (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Cost of revenue – subscription $ 3,186 $ 2,977 $ 9,139 $ 8,902 Sales and marketing — 1,232 2,143 3,695 Total amortization of acquired intangible assets $ 3,186 $ 4,209 $ 11,282 $ 12,597
Schedule of Expected Future Amortization Expense of Intangible Assets	The expected future amortization expense related to the intangible assets as of January 31, 2024 was as follows (in thousands, by fiscal year): Remainder of 2024 $ 3,098 2025 9,239 2026 6,278 2027 3,267 2028 1,224 Thereafter 716 Total $ 23,822
Schedule of Changes to Goodwill	The following table represents the changes to goodwill (in thousands): Carrying Amount Balance as of April 30, 2023 $ 303,642 Addition from acquisition 15,830 Foreign currency translation adjustment 74 Balance as of January 31, 2024 $ 319,546
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): As of As of Accrued expenses $ 30,697 $ 24,163 Income taxes payable 14,628 9,738 Value added taxes payable 5,360 9,403 Accrued interest 988 6,918 Other 13,162 13,310 Total accrued expenses and other liabilities $ 64,835 $ 63,532
Schedule of Accrued Compensation and Benefits	Accrued compensation and benefits consisted of the following (in thousands): As of As of Accrued vacation $ 31,346 $ 30,026 Accrued commissions 18,946 26,175 Accrued payroll and withholding taxes 13,495 6,586 Other 14,262 13,696 Total accrued compensation and benefits $ 78,049 $ 76,483
Schedule of Unbilled Accounts Receivable, Deferred Contract Acquisition Costs, and Deferred Revenue from Contracts with Customers	The following is a summary of the changes in the Company’s allowance for credit losses (in thousands): Nine Months Ended January 31, 2024 2023 Beginning balance $ 3,409 $ 2,700 Bad debt expense 2,189 1,276 Accounts written off (1,733) (1,781) Ending balance $ 3,865 $ 2,195

Senior Notes (Tables)

Senior Notes (Tables)	9 Months Ended
	Jan. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-Term Debt Instruments	The net carrying amount of the Senior Notes was as follows (in thousands): As of As of Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (6,659) (7,457) Net carrying amount $ 568,341 $ 567,543 The following table sets forth the interest expense recognized related to the Senior Notes (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Contractual interest expense $ 5,930 $ 5,930 $ 17,789 $ 17,789 Amortization of debt issuance costs 269 257 798 763 Total interest expense related to the Senior Notes $ 6,199 $ 6,187 $ 18,587 $ 18,552

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jan. 31, 2024
Leases [Abstract]
Components of Lease Costs	Components of lease costs included in the condensed consolidated statements of operations were as follows (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Operating lease cost $ 3,120 $ 3,088 $ 8,960 $ 9,539 Short-term lease cost 334 381 1,308 1,729 Variable lease cost 527 219 1,049 446 Total lease cost $ 3,981 $ 3,688 $ 11,317 $ 11,714
Lease Term and Discount Rate Information	Lease term and discount rate information are summarized as follows: As of Weighted average remaining lease term (in years) 2.85 Weighted average discount rate 5.10 %
Future Minimum Lease Payments Based on Current Lease Accounting Standard	Future minimum lease payments under non-cancelable operating leases on an undiscounted cash flow basis as of January 31, 2024 were as follows (in thousands, by fiscal year): Remainder of 2024 $ 3,603 2025 12,955 2026 7,398 2027 2,704 2028 2,359 Thereafter 1,101 Total minimum lease payments 30,120 Less imputed interest (2,035) Present value of future minimum lease payments 28,085 Less current lease liabilities (12,788) Operating lease liabilities, non-current $ 15,297

Ordinary Shares (Tables)

Ordinary Shares (Tables)	9 Months Ended
	Jan. 31, 2024
Equity [Abstract]
Summary of Ordinary Shares Reserved for Issuance	The Company has reserved ordinary shares for issuance as follows: As of As of Stock options issued and outstanding 2,732,289 4,038,238 RSUs issued and outstanding (1) 7,895,146 7,494,399 Available for future grants 20,105,501 17,564,133 Available for employee stock purchases 5,805,895 6,000,000 Total ordinary shares reserved 36,538,831 35,096,770 (1) Includes 116,523 PSUs issued and outstanding as of January 31, 2024.

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Equity Awards Available for Grant	The equity awards available for grant were as follows: Nine Months Ended January 31, 2024 Available at beginning of fiscal year 17,564,133 Awards authorized 4,868,347 Options canceled 104,137 RSUs granted (1) (3,261,660) RSUs canceled (2) 830,544 Available at end of period 20,105,501 (1) Includes 132,960 PSUs granted during the nine months ended January 31, 2024. (2) Includes 16,437 PSUs canceled during the nine months ended January 31, 2024.
Summary of Stock Option Activity	The following table summarizes stock option activity: Stock Options Outstanding Number of Stock Options Outstanding Weighted- Average Exercise Price Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Balance as of April 30, 2023 4,038,238 $ 32.74 5.35 $ 134,778 Stock options exercised (1,200,589) $ 16.23 Stock options canceled (104,137) $ 98.35 Stock options assumed in acquisition canceled (1,223) $ 75.42 Balance as of January 31, 2024 2,732,289 $ 37.47 4.89 $ 223,029 Exercisable as of January 31, 2024 2,439,399 $ 30.88 4.57 $ 214,206
Summary of RSU Activity	The following table summarizes RSU activity under the 2012 Plan: Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at April 30, 2023 7,494,399 $ 74.52 RSUs granted (1) 3,261,660 $ 102.08 RSUs released (2,030,369) $ 79.51 RSUs canceled (2) (830,544) $ 74.41 Outstanding and unvested at January 31, 2024 7,895,146 $ 84.64 (1) Includes 132,960 PSUs granted during the nine months ended January 31, 2024. (2) Includes 16,437 PSUs canceled during the nine months ended January 31, 2024.
Summary of Stock-based Compensation Expense Related to Tender Offer Included in Consolidated Statement of Operations	Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations was as follows (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Cost of revenue Subscription $ 2,253 $ 2,163 $ 6,553 $ 6,352 Services 3,331 2,529 8,980 7,067 Research and development 24,443 20,905 68,843 58,378 Sales and marketing 20,238 19,096 57,252 50,756 General and administrative 12,497 9,763 34,716 26,073 Total stock-based compensation expense $ 62,762 $ 54,456 $ 176,344 $ 148,626

Net Earnings (Loss) Per Share_2

Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders (Tables)	9 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Ordinary Shareholders	The following table sets forth the computation of basic and diluted net earnings (loss) per share attributable to ordinary shareholders (in thousands, except share and per share data): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Numerator: Net income (loss) $ 176,124 $ (72,574) $ 102,820 $ (189,430) Denominator: Weighted-average shares used in computing net earnings (loss) per share attributable to ordinary shareholders Basic 100,282,179 96,052,025 99,099,210 95,327,131 Diluted 104,503,290 96,052,025 103,149,384 95,327,131 Net earnings (loss) per share attributable to ordinary shareholders, basic and diluted Basic $ 1.76 $ (0.76) $ 1.04 $ (1.99) Diluted $ 1.69 $ (0.76) $ 1.00 $ (1.99)
Schedule of Outstanding Potentially Dilutive Ordinary Shares Excluded from Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders	The following outstanding potentially dilutive ordinary shares were excluded from the computation of diluted net earnings (loss) per share attributable to ordinary shareholders for the periods presented because the impact of including them would have been antidilutive: Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Stock options 344,995 4,419,457 780,199 4,419,457 RSUs 1,858,725 8,021,408 1,467,263 8,021,408 2022 ESPP — — 641 — Total 2,203,720 12,440,865 2,248,103 12,440,865

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Jan. 31, 2024
Segment Reporting [Abstract]
Schedule of Revenue by Geographic Area	The following table summarizes the Company’s total revenue by geographic area based on the location of customers (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 United States $ 186,177 $ 159,125 $ 537,392 $ 464,186 Rest of world 141,780 115,441 394,930 324,862 Total revenue $ 327,957 $ 274,566 $ 932,322 $ 789,048
Schedule of Property and Equipment, Net of Depreciation	The following table presents the Company’s long-lived assets, including property and equipment, net, and operating lease right-of-use assets, by geographic region (in thousands): As of As of United States $ 11,983 $ 13,476 The Netherlands 3,959 4,597 United Kingdom 4,030 2,797 India 2,679 1,803 Rest of world 5,949 2,416 Total long-lived assets $ 28,600 $ 25,089

Revenue - Schedule of Revenue b

Revenue - Schedule of Revenue by Category (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 327,957	$ 274,566	$ 932,322	$ 789,048
Revenue | Product
Disaggregation of Revenue [Line Items]
% of Total Revenue	100%	100%	100%	100%
Total subscription
Disaggregation of Revenue [Line Items]
Total revenue	$ 307,632	$ 255,613	$ 865,622	$ 728,638
Total subscription | Revenue | Product
Disaggregation of Revenue [Line Items]
% of Total Revenue	94%	93%	93%	92%
SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 143,379	$ 110,743	$ 399,540	$ 311,709
SaaS | Revenue | Product
Disaggregation of Revenue [Line Items]
% of Total Revenue	44%	40%	43%	40%
Self-managed subscription
Disaggregation of Revenue [Line Items]
Total revenue	$ 164,253	$ 144,870	$ 466,082	$ 416,929
Self-managed subscription | Revenue | Product
Disaggregation of Revenue [Line Items]
% of Total Revenue	50%	53%	50%	52%
Professional services
Disaggregation of Revenue [Line Items]
Total revenue	$ 20,325	$ 18,953	$ 66,700	$ 60,410
Professional services | Revenue | Product
Disaggregation of Revenue [Line Items]
% of Total Revenue	6%	7%	7%	8%

Revenue - Additional Informatio

Revenue - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($) Customer	Jan. 31, 2022 Customer	Apr. 30, 2023 USD ($)
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	$ 1,176,000		$ 1,176,000
Revenue, remaining performance obligation, percentage	91%		91%
Revenue, remaining performance obligation, remaining duration	24 months		24 months
Disaggregation of Revenue [Line Items]
Deferred revenue, revenue recognized	$ 103,200	$ 86,100	$ 474,400	$ 387,400
Revenue, remaining performance obligation, amount	$ 1,176,000		$ 1,176,000
Revenue, remaining performance obligation, percentage	91%		91%
Revenue, remaining performance obligation, remaining duration	24 months		24 months
Amortization of deferred contract acquisition costs	$ 20,400	$ 15,800	$ 56,392	$ 51,495
Contracts with Customers
Disaggregation of Revenue [Line Items]
Unbilled accounts receivable	$ 3,100		$ 3,100			$ 2,200
Net Accounts Receivable | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Number of customers | Customer				1	1
Net Accounts Receivable | Customer Concentration Risk | Customer One
Disaggregation of Revenue [Line Items]
Concentration risk percentage				12%
Revenue, Product and Service Benchmark | Customer Concentration Risk | Customer One
Disaggregation of Revenue [Line Items]
Concentration risk percentage			11%

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets are Measured at Fair Value on Recurring Basis (Details) - Recurring - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 207,069	$ 304,167
Total marketable securities	488,133	271,041
Total financial assets	695,202	575,208
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	204,839	194,261
Total marketable securities	109,777	47,627
Total financial assets	314,616	241,888
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	2,230	109,906
Total marketable securities	378,356	223,414
Total financial assets	380,586	333,320
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0	0
Total marketable securities	0	0
Total financial assets	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	189,846	194,261
Total marketable securities	33,177	31,645
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	189,846	194,261
Total marketable securities	0	0
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0	0
Total marketable securities	33,177	31,645
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0	0
Total marketable securities	0	0
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	14,993
Total marketable securities	109,777	47,627
U.S. treasury securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	14,993
Total marketable securities	109,777	47,627
U.S. treasury securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Total marketable securities	0	0
U.S. treasury securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Total marketable securities	0	0
International treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	7,188
International treasuries | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0
International treasuries | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	7,188
International treasuries | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	2,230	21,750
Certificates of deposit | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0	0
Certificates of deposit | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	2,230	21,750
Certificates of deposit | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0	0
Municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	25,894
Municipal securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0
Municipal securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	25,894
Municipal securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		60,750
Total marketable securities	38,757	33,735
Commercial paper | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		0
Total marketable securities	0	0
Commercial paper | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		60,750
Total marketable securities	38,757	33,735
Commercial paper | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		0
Total marketable securities	0	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	232,030	118,228
Corporate debt securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
Corporate debt securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	232,030	118,228
Corporate debt securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
U.S. agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		27,406
Total marketable securities	41,310	39,806
U.S. agency bonds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		0
Total marketable securities	0	0
U.S. agency bonds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		27,406
Total marketable securities	41,310	39,806
U.S. agency bonds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets		0
Total marketable securities	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Interest Income, Interest-Earning Asset		$ 7,800,000	$ 6,200,000	$ 20,900,000	$ 10,900,000
Proceeds from Issuance of Senior Long-term Debt	$ 575,000,000
Debt Instrument, Interest Rate, Stated Percentage	4.125%
Long-term Debt, Fair Value		$ 523,000,000		$ 523,000,000

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value by Maturity Date (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Due within 1 year	$ 252,415	$ 168,264
Due between 1 year and 3 years	235,718	102,777
Total marketable securities	$ 488,133	$ 271,041

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ in Thousands		9 Months Ended
	Nov. 30, 2023	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Business Acquisition [Line Items]
Goodwill		$ 319,546		$ 303,642
Acquired identifiable intangible assets amortization period		2 years 9 months 18 days	2 years 6 months
Developed technology
Business Acquisition [Line Items]
Acquired identifiable intangible assets amortization period		2 years 9 months 18 days	2 years 8 months 12 days
Opster
Business Acquisition [Line Items]
Share capital acquired in business combination (in percentage)	100%
Purchase consideration	$ 22,800
Consideration held back for idemnity obligations	3,100
Goodwill	15,900
Opster | Developed technology
Business Acquisition [Line Items]
Intangible assets acquired	$ 6,000
Acquired identifiable intangible assets amortization period	5 years

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Cost and Accumulated Depreciation of Property and Equipment (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 23,140	$ 20,128
Less: accumulated depreciation	(17,628)	(15,036)
Property and equipment, net	5,512	5,092
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 12,281	10,081
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	3 years
Total property and equipment	$ 3,310	2,220
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 6,898	6,093
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	3 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful lives	5 years
Assets under construction
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 651	$ 1,734

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Balance Sheet Components [Abstract]
Depreciation expense	$ 900,000	$ 800,000	$ 2,600,000	$ 2,900,000
Goodwill impairment			0	0
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 900,000	800,000	$ 2,600,000	2,900,000
Furniture, Equipment, And Leasehold Improvements
Property, Plant and Equipment [Line Items]
Impairment charges		$ 1,100,000		$ 1,100,000

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Fair Value	$ 98,600		$ 92,600
Accumulated Amortization	74,745		63,463
Net Book Value	$ 23,855		29,137
Weighted Average Remaining Useful Life (in years)	2 years 9 months 18 days	2 years 6 months
Foreign currency translation adjustment	$ (33)		(33)
Total	23,822		29,104
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Fair Value	76,130		70,130
Accumulated Amortization	52,275		43,136
Net Book Value	$ 23,855		26,994
Weighted Average Remaining Useful Life (in years)	2 years 9 months 18 days	2 years 8 months 12 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Fair Value	$ 19,598		19,598
Accumulated Amortization	19,598		17,641
Net Book Value	$ 0		1,957
Weighted Average Remaining Useful Life (in years)	0 years	4 months 24 days
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross Fair Value	$ 2,872		2,872
Accumulated Amortization	2,872		2,686
Net Book Value	$ 0		$ 186
Weighted Average Remaining Useful Life (in years)	0 years	4 months 24 days

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Amortization Expense For Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	$ 3,186	$ 4,209	$ 11,282	$ 12,597
Foreign currency translation adjustment	(33)		(33)		$ (33)
Total	23,822		23,822		$ 29,104
Cost of revenue | Subscription - self-managed and SaaS
Finite-Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	3,186	2,977	9,139	8,902
Sales and marketing
Finite-Lived Intangible Assets [Line Items]
Total amortization of acquired intangible assets	$ 0	$ 1,232	$ 2,143	$ 3,695

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Expected Future Amortization Expense of the Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 3,098
2025	9,239
2026	6,278
2027	3,267
2028	1,224
Thereafter	716
Total	$ 23,822	$ 29,104

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Changes to Goodwill (Details) $ in Thousands	9 Months Ended
	Jan. 31, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 303,642
Addition from acquisition	15,830
Foreign currency translation adjustment	74
Ending balance	$ 319,546

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Balance Sheet Components [Abstract]
Accrued expenses	$ 30,697	$ 24,163
Income taxes payable	14,628	9,738
Value added taxes payable	5,360	9,403
Other	13,162	13,310
Total accrued expenses and other liabilities	64,835	63,532
Accrued interest on Senior Notes	$ 988	$ 6,918

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Balance Sheet Components [Abstract]
Accrued vacation	$ 31,346	$ 30,026
Accrued commissions	18,946	26,175
Accrued payroll and withholding taxes	13,495	6,586
Other	14,262	13,696
Total accrued compensation and benefits	$ 78,049	$ 76,483

Balance Sheet Components - Liab

Balance Sheet Components - Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Beginning balance	$ 3,409	$ 2,700
Bad debt expense	2,189	1,276
Accounts written off	(1,733)	(1,781)
Ending balance	$ 3,865	$ 2,195

Senior Notes - Additional Infor

Senior Notes - Additional Information (Details) - USD ($)	1 Months Ended
	Jul. 31, 2021	Jan. 31, 2024	Apr. 30, 2023
Debt Instrument [Line Items]
Proceeds from Issuance of Senior Long-term Debt	$ 575,000,000
Debt Instrument, Interest Rate, Stated Percentage	4.125%
Long-term debt, net		$ 568,341,000	$ 567,543,000
Senior Notes
Debt Instrument [Line Items]
Proceeds from Issuance of Senior Long-term Debt	$ 575,000,000
Debt Instrument, Interest Rate, Stated Percentage	4.125%
Long-term debt, net	$ 565,700,000
underwriting commissions	7,200,000
Other issuance cost	2,100,000
Debt Issuance Costs, Gross	$ 9,300,000
Repurchase of debt (as a percent)	101%
Senior Notes | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Redemption price (as a percent)	100%
Redemption price of principal (as a percent)	40%
Senior Notes | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Redemption price (as a percent)	104.125%
Senior Notes | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Redemption price (as a percent)	100%

Senior Notes - Carrying Amount

Senior Notes - Carrying Amount of Senior Notes And Interest Expense Recognized (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Debt Disclosure [Abstract]
Principal	$ 575,000		$ 575,000		$ 575,000
Unamortized debt issuance costs	(6,659)		(6,659)		(7,457)
Long-term debt, net	568,341		568,341		$ 567,543
Contractual interest expense	5,930	$ 5,930	17,789	$ 17,789
Amortization of debt issuance costs	269	257	798	763
Total interest expense related to the Senior Notes	$ 6,199	$ 6,187	$ 18,587	$ 18,552

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details)	9 Months Ended
	Jan. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding amount	$ 2,300,000
Provision for indemnification claims	$ 0

Leases - Components of Lease Co

Leases - Components of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Leases [Abstract]
Operating lease cost	$ 3,120	$ 3,088	$ 8,960	$ 9,539
Short-term lease cost	334	381	1,308	1,729
Variable lease cost	527	219	1,049	446
Total lease cost	$ 3,981	$ 3,688	$ 11,317	$ 11,714

Leases - Lease Term and Discoun

Leases - Lease Term and Discount Rate Information (Details)	Jan. 31, 2024
Leases [Abstract]
Weighted average remaining lease term (in years)	2 years 10 months 6 days
Weighted average discount rate	5.10%

Leases - Future Minimum Lease B

Leases - Future Minimum Lease Based on Current Lease Accounting Standard (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Leases [Abstract]
Remainder of 2024	$ 3,603
2025	12,955
2026	7,398
2027	2,704
2028	2,359
Thereafter	1,101
Total minimum lease payments	30,120
Less imputed interest	(2,035)
Present value of future minimum lease payments	28,085
Less current lease liabilities	(12,788)	$ (12,749)
Operating lease liabilities, non-current	$ 15,297	$ 13,942

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jan. 31, 2024	Jan. 31, 2024	Jan. 31, 2023
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]
Asset impairment charges		$ 0	$ 6,242
Leased Office Space
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]
Asset impairment charges	$ 5,100	$ 5,100

Ordinary Shares - Additional In

Ordinary Shares - Additional Information (Details)	9 Months Ended
	Jan. 31, 2024 € / shares	Jan. 31, 2024 USD ($) shares	Apr. 30, 2023 shares	Oct. 10, 2018 shares
Class of Stock [Line Items]
Common Stock, Shares Authorized		165,000,000
Ordinary shares, voting rights	one vote per ordinary share
Dividends declared | $		$ 0
Convertible Preference Shares
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		165,000,000	165,000,000	165,000,000
Preferred Stock, Shares Issued		0	0
Preferred Stock, Shares Outstanding		0	0
Maximum
Class of Stock [Line Items]
Ordinary shares, par value (in € / shares) | € / shares	€ 0.01

Ordinary Shares - Summary of Or

Ordinary Shares - Summary of Ordinary Shares Reserved for Issuance (Details) - shares	Jan. 31, 2024	Apr. 30, 2023
Class of Stock [Line Items]
Total ordinary shares reserved (in shares)	36,538,831	35,096,770
Stock options
Class of Stock [Line Items]
Total ordinary shares reserved (in shares)	2,732,289	4,038,238
RSUs
Class of Stock [Line Items]
Total ordinary shares reserved (in shares)	7,895,146	7,494,399
Performance Shares
Class of Stock [Line Items]
Total ordinary shares reserved (in shares)	116,523
2012 Plan
Class of Stock [Line Items]
Total ordinary shares reserved (in shares)	20,105,501	17,564,133
Employee Stock Purchase Plan 2022
Class of Stock [Line Items]
Total ordinary shares reserved (in shares)	5,805,895	6,000,000

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2022	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 62,762	$ 54,456	$ 176,344	$ 148,626
Weighted-average grant-date fair value of options granted (in dollar per share)					$ 48.56
Unrecognized stock-based compensation expense related to unvested stock options		$ 15,800		$ 15,800
2012 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)			0
2012 Plan | New Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term (in years)				4 years
ESPP | Employee Stock Purchase Plan 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of shares reserved	$ 6,000
Purchase price of common stock, percent of market price	85%
Purchase period (in months)	6 months
Issuance of ordinary shares under employee stock purchase plan (in shares)		0		194,105
Stock-based compensation expense		$ 1,700		$ 5,300
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized over a weighted-average period (in years)				1 year 9 months 29 days
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Awards, RSUs granted (in shares)				132,960
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding		9,100		$ 9,100
Performance Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted				0%
Performance Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted				20,000%
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized over a weighted-average period (in years)				2 years 11 months 19 days
Number of Awards, RSUs granted (in shares)				3,261,660
RSUs | 2012 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Awards, RSUs granted (in shares)				3,261,660
Equity Settled RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense related to unvested stock options		$ 624,800		$ 624,800

Equity Incentive Plans - Summar

Equity Incentive Plans - Summary of Equity Awards Available for Grant (Details)	9 Months Ended
	Jan. 31, 2024 shares
Equity Awards, Outstanding [Roll Forward]
Available at beginning of fiscal year (in shares)	17,564,133
Awards authorized (in shares)	4,868,347
Options cancelled (in shares)	104,137
Available at end of fiscal year (in shares)	20,105,501
RSUs
Equity Awards, Outstanding [Roll Forward]
RSUs granted (in shares)	(3,261,660)
RSUs cancelled (in shares)	830,544
Performance Shares
Equity Awards, Outstanding [Roll Forward]
RSUs granted (in shares)	(132,960)
RSUs cancelled (in shares)	16,437

Equity Incentive Plans - Summ_2

Equity Incentive Plans - Summary of Stock Option Activity (Details) - 2012 Plan $ / shares in Units, $ in Thousands	9 Months Ended
	Jan. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2023
Options, Outstanding Number [Roll Forward]
Beginning balance (in shares) | shares	4,038,238
Stock options assumed in acquisition (in shares) | shares	(1,200,589)
Stock options exercised (in shares) | shares	(104,137)
Stock options cancelled (in shares) | shares	(1,223)
Ending balance (in shares) | shares	2,732,289
Exercisable (in shares) | shares	2,439,399
Options Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance (in dollars per share) | $ / shares	$ 32.74
Stock options assumed in acquisition (in dollars per share) | $ / shares	16.23
Stock options exercised (in dollars per share) | $ / shares	98.35
Stock options cancelled (in dollars per share) | $ / shares	75.42
Ending balance (in dollars per share) | $ / shares	37.47
Exercisable (in dollars per share) | $ / shares	$ 30.88
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Rollforward
Remaining Contractual Term (in years)	4 years 10 months 20 days	5 years 4 months 6 days
Exercisable, Remaining Contractual Term (in years)	4 years 6 months 25 days
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Rollforward
Beginning balance | $	$ 134,778
Ending balance | $	223,029
Exercisable | $	$ 214,206

Equity Incentive Plans - Summ_3

Equity Incentive Plans - Summary of RSU Activity (Details)	9 Months Ended
	Jan. 31, 2024 $ / shares shares
RSUs
Non-option Awards, Outstanding Number [Roll Forward]
Number of Awards, RSUs granted (in shares)	3,261,660
Number of Awards, RSUs cancelled (in shares)	(830,544)
Non-option Awards, Weighted Average Grant Date Fair Value [Roll Forward]
Unrecognized over a weighted-average period (in years)	2 years 11 months 19 days
Performance Shares
Non-option Awards, Outstanding Number [Roll Forward]
Number of Awards, RSUs granted (in shares)	132,960
Number of Awards, RSUs cancelled (in shares)	(16,437)
2012 Plan | RSUs
Non-option Awards, Outstanding Number [Roll Forward]
Number of Awards Outstanding and unvested at Beginning of Year ((in shares)	7,494,399
Number of Awards, RSUs granted (in shares)	3,261,660
Number of Awards, RSUs released (in shares)	(2,030,369)
Number of Awards, RSUs cancelled (in shares)	(830,544)
Number of Awards Outstanding and unvested at Year End (in shares)	7,895,146
Non-option Awards, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted-Average Grant Date Fair Value, Outstanding and unvested, Beginning of Year (in dollar per share) | $ / shares	$ 74.52
Weighted-Average Grant Date Fair Value, RSUs granted (in dollar per share) | $ / shares	102.08
Weighted-Average Grant Date Fair Value, RSUs released (in dollar per share) | $ / shares	79.51
Weighted-Average Grant Date Fair Value, RSUs cancelled (in dollar per share) | $ / shares	74.41
Weighted-Average Grant Date Fair Value, Outstanding and unvested, End of Year (in dollar per share) | $ / shares	$ 84.64

Equity Incentive Plans - Summ_4

Equity Incentive Plans - Summary of Stock-based Compensation Expense Recognized in Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 62,762	$ 54,456	$ 176,344	$ 148,626
Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	2,253	2,163	6,553	6,352
Services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	3,331	2,529	8,980	7,067
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	24,443	20,905	68,843	58,378
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	20,238	19,096	57,252	50,756
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 12,497	$ 9,763	$ 34,716	$ 26,073

Net Earnings (Loss) Per Share_3

Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Ordinary Shareholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Numerator:
Net income (loss)	$ 176,124	$ (72,574)	$ 102,820	$ (189,430)
Weighted-average shares used in computing net earnings (loss) per share attributable to ordinary shareholders
Basic (in shares)	100,282,179	96,052,025	99,099,210	95,327,131
Diluted (in shares)	104,503,290	96,052,025	103,149,384	95,327,131
Net earnings (loss) per share attributable to ordinary shareholders
Basic (in dollars per share)	$ 1.76	$ (0.76)	$ 1.04	$ (1.99)
Diluted (in dollars per share)	$ 1.69	$ (0.76)	$ 1	$ (1.99)

Net Earnings (Loss) Per Share_4

Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Outstanding Potentially Dilutive Ordinary Shares Excluded from Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders (Details) - shares	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,203,720	12,440,865	2,248,103	12,440,865
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	344,995	4,419,457	780,199	4,419,457
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,858,725	8,021,408	1,467,263	8,021,408
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	0	641	0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Tax Disclosure [Abstract]
(Benefit from) provision for income taxes	$ (200,328)	$ 2,422	$ (181,926)	$ 12,313
Valuation allowance, released amount			$ (250,700)

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
United States
Defined Contribution Plan Disclosure [Line Items]
Defined contribution expense related to plan	$ 4.2	$ 4.4	$ 13.3	$ 13.4
Other Countries
Defined Contribution Plan Disclosure [Line Items]
Defined contribution expense related to plan	$ 3.5	$ 2.4	$ 9.4	$ 6.9
Maximum | United States
Defined Contribution Plan Disclosure [Line Items]
Percentage of defined contribution to participating employees			6%

Segment Information - Schedule

Segment Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 327,957	$ 274,566	$ 932,322	$ 789,048
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	186,177	159,125	537,392	464,186
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 141,780	$ 115,441	$ 394,930	$ 324,862

Segment Information - Schedul_2

Segment Information - Schedule of Property and Equipment, Net of Depreciation (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	$ 28,600	$ 25,089
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	11,983	13,476
The Netherlands
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	3,959	4,597
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	4,030	2,797
India
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	2,679	1,803
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets	$ 5,949	$ 2,416

Restructuring and Other Relat_2

Restructuring and Other Related Charges - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Nov. 30, 2022	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges		$ 0	$ 29,805	$ 754	$ 29,805
Asset impairment charges				0	6,242
Leased Office Space
Restructuring Cost and Reserve [Line Items]
Asset impairment charges		5,100		5,100
Furniture, Equipment, And Leasehold Improvements
Restructuring Cost and Reserve [Line Items]
Impairment charges			1,100		1,100
Employee Severance
Restructuring Cost and Reserve [Line Items]
Decrease in workforce (as a percent)	13%
Restructuring and other related charges		$ 0	22,000	$ 800	22,000
Facilities-related charges			$ 6,200		$ 6,200

Uncategorized Items - estc-2024

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	$ 863,637,000